CJC-1295 w/ DAC (5ml)
$59.00
A GHRH analog conjugated to a Drug Affinity Complex for extended albumin binding and half-life, studied in laboratory research for sustained somatotropic axis stimulation.
Buy 1
SAVE 0%
Buy 3
SAVE 20%
Buy 5
SAVE 33%
Buy 7+
SAVE 50%
Description
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic GHRH analog modified with a lysine-based DAC technology that enables covalent binding to circulating serum albumin, significantly extending its biological half-life relative to unmodified GHRH or CJC-1295 without DAC. This pharmacokinetic modification has been the subject of clinical and laboratory research examining sustained GH secretion profiles and prolonged IGF-1 elevation over extended periods.
The DAC modification represents a distinct pharmacological approach from pulsatile GHRH analogs and has been studied for its effects on the pattern and duration of somatotropic axis activation. Laboratory research exploring the biological consequences of extended versus pulsatile GH signaling has made CJC-1295 with DAC a valuable comparative research tool.
Supplied as a lyophilized Research Use Only (RUO) material, analytically verified for identity and purity with batch-specific Certificate of Analysis documentation.
